Our commitment to innovation drives us to continually refine and enhance the butterfly iv cannula, ensuring superior performance and patient outcomes
Reduced graphene oxide (rGO) was synthesized using our previously reported protocol 60
It is a dietary supplement

Water, Dipropylene Glycol, Galactomyces Ferment Filtrate, Glycerin, Methylpropanediol, Glycereth-26, Niacinamide, Glyceryl Glucoside, Glyceryl Polymethacrylate, Erythritol, Polyglyceryl-10 Laurate, Hydroxyacetophenone, 1,2-Hexanediol, Carbomer, Caprylyl Glycol, Arginine, Hydrolyzed Jojoba Esters, Xanthan Gum, Adenosine, Glucose, Ethylhexylglycerin, Butylene Glycol, Citric Acid, Ascorbic Acid, Polyquaternium-51, Panthenol, Citrus Aurantium Bergamia Fruit Oil, Diethylhexyl Sodium Sulfosuccinate, Sodium Citrate, Lavandula Angustifolia Oil, Glutathione, Sodium Hyaluronate, Dipotassium Glycyrrhizate, Oryza Sativa Extract, Pyrus Malus Fruit Extract, Saccharide Isomerate, Hydrogenated Lecithin, Pantolactone, Maltodextrin, Brassica Oleracea Italica Extract, Hydrolyzed Vegetable Protein, Prunus Serrulata Flower Extract, Nelumbo Nucifera Germ Extract, Lilium Tigrinum Extract, Copper Tripeptide-1, Hydrolyzed Hyaluronic Acid, Hyaluronic Acid, Sodium Hyaluronate Crosspolymer, Hydroxypropyltrimonium Hyaluronate, Potassium Hyaluronate, Hydrolyzed Sodium Hyaluronate, Pentylene Glycol, Sodium Acetylated Hyaluronate, Disodium EDTA, Limonene, Linalool

Ginkgetin alleviates high glucose-evoked mesangial cell oxidative stress injury, inflammation, and extracellular matrix (ECM) deposition in an AMPK/mTOR-mediated autophagy axis
doi: 10.3233/JAD-190198